Emergence of New Delhi Metallo-Beta-Lactamase (NDM-1) and Klebsiella pneumoniae Carbapenemase (KPC-2) in South Africa

被引：79

作者：

Brink, Adrian J. ^{[1
]}

Coetzee, Jennifer ^{[2
]}

Clay, Cornelis G. ^{[2
]}

Sithole, Sindi ^{[3
]}

Richards, Guy A. ^{[4
,5
]}

Poirel, Laurent ^{[6
,7
]}

Nordmann, Patrice ^{[6
,7
]}

机构：

[1] Milpark Hosp, Ampath Natl Lab Serv, Dept Clin Microbiol, Johannesburg, South Africa

[2] Natl Referral Lab, Ampath Natl Lab Serv, Dept Clin Microbiol & Mol Biol, Centurion, South Africa

[3] Glynwood Hosp, Ampath Natl Lab Serv, Dept Clin Microbiol, Johannesburg, South Africa

[4] Charlotte Maxeke Johannesburg Acad Hosp, Dept Crit Care, Johannesburg, South Africa

[5] Univ Witwatersrand, Johannesburg, South Africa

[6] Hop Bicetre, AP HP, Fac Med, Serv Bacteriol Virol,INSERM Emerging Resistance A, K Bicetre, France

[7] Univ Paris 11, K Bicetre, France

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2012年 / 50卷 / 02期

关键词：

RESISTANCE; INFECTION; SPREAD;

D O I：

10.1128/JCM.05956-11

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

This report documents emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in K. pneumoniae and Enterobacter cloacae in South Africa. NDM-1 producers have not been described in South Africa, and this is the first instance that KPC producers have been identified in Africa. The two patients infected with these carbapenemase-producing bacteria demised.

引用

页码：525 / 527

页数：3

共 17 条

[1]

[Anonymous], 2011, Performance standards for antimicrobial disk susceptibility tests

[2]

approved standard M2-A11, V11th

[3] Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control [J].

Carmeli, Y. ;

Akova, M. ;

Cornaglia, G. ;

Daikos, G. L. ;

Garau, J. ;

Harbarth, S. ;

Rossolini, G. M. ;

Souli, M. ;

Giamarellou, H. .

CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (02) :102-111

[4] In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum β-lactamase [J].

Elliott, E ;

Brink, AJ ;

van Greune, J ;

Els, Z ;

Woodford, N ;

Turton, J ;

Warner, M ;

Livermore, DM .

CLINICAL INFECTIOUS DISEASES, 2006, 42 (11) :E95-E98

[5]

European Committee on Antimicrobial Susceptibility Testing, 2009, BREAKP TABL INT MICS

[6]

Grundmann H, 2010, EUROSURVEILLANCE, V15, P22

[7] Rapid detection of blaKPC carbapenemase genes by real-time PCR [J].

Hindiyeh, Musa ;

Smollen, Gill ;

Grossman, Zehava ;

Ram, Daniela ;

Davidson, Yehudit ;

Mileguir, Fernando ;

Vax, Marina ;

Ben David, Debbie ;

Tal, Ilana ;

Rahav, Galia ;

Shamiss, Ari ;

Mendelson, Ella ;

Keller, Nathan .

JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (09) :2879-2883

[8] Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection [J].

Hirsch, Elizabeth B. ;

Tam, Vincent H. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (06) :1119-1125

[9] Antibiotic use and the risk of carbapenem-resistant extended-spectrum-β-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study [J].

Kritsotakis, Evangelos I. ;

Tsioutis, Constantinos ;

Roumbelaki, Maria ;

Christidou, Athanasia ;

Gikas, Achilleas .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (06) :1383-1391

[10]

Nordmann P, 2011, J CLIN MICROBIOL, V41, P798

← 1 2 →